Titanium vs Polymer Spinal Cages for Spinal Conditions
Trial Summary
What is the purpose of this trial?
This trial is testing two different types of spinal implants in patients needing back surgery to see which one works better. The implants help stabilize the spine and promote bone growth to fuse the vertebrae together.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on medications that interfere with bone or soft tissue healing, like certain steroids or immunosuppressives.
What data supports the effectiveness of the treatment Medtronic Adaptix™ titanium implants and Medtronic CAPSTONE® PEEK cage for spinal conditions?
Is it safe to use titanium or PEEK spinal cages in humans?
How is the treatment with Medtronic Adaptix™ titanium implants and Medtronic CAPSTONE® PEEK cage different from other treatments for spinal conditions?
This treatment is unique because it compares the use of titanium implants, known for their strength and osseointegration (ability to bond with bone), with PEEK cages, which are favored for their radiologic visibility and compatibility with MRI scans. The study aims to evaluate the fusion behavior and bacterial adhesion characteristics of these materials, which are important factors in spinal surgeries.12589
Research Team
Eligibility Criteria
Adults over 18 needing lumbar fusion surgery for conditions like spondylolisthesis or degenerative disc disease, who've had no relief from 6 months of conservative care. Excludes those with prior lumbar surgery, certain medical conditions, obesity (BMI >45), infections, metal sensitivities, substance abuse history, pregnancy/lactation plans within a year, and involvement in litigation or other studies.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo lumbar fusion surgery using either Medtronic Adaptix™ titanium implants or CAPSTONE® PEEK cages, supplemented with a pedicle screw system and a 50:50 mixture of autograft: allograft.
Follow-up
Participants are monitored for clinical and radiographic outcomes, with assessments at 3, 6, 12, and 24 months post-surgery.
Treatment Details
Interventions
- Medtronic Adaptix™ titanium implants (Implant)
- Medtronic CAPSTONE® PEEK cage (Implant)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University
Lead Sponsor
Dr. John J. Warner
Ohio State University
Chief Executive Officer since 2023
MD, MBA
Dr. Peter Mohler
Ohio State University
Chief Medical Officer since 2023
PhD in Molecular Biology